WO1998051327A1 - Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats - Google Patents

Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats Download PDF

Info

Publication number
WO1998051327A1
WO1998051327A1 PCT/JP1998/002031 JP9802031W WO9851327A1 WO 1998051327 A1 WO1998051327 A1 WO 1998051327A1 JP 9802031 W JP9802031 W JP 9802031W WO 9851327 A1 WO9851327 A1 WO 9851327A1
Authority
WO
WIPO (PCT)
Prior art keywords
prophylactic
canine
feline
agent
immunological diseases
Prior art date
Application number
PCT/JP1998/002031
Other languages
English (en)
French (fr)
Inventor
Fumiyoshi Okano
Masahiro Satoh
Katsushige Yamada
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Priority to AU72343/98A priority Critical patent/AU739107B2/en
Priority to CA002265505A priority patent/CA2265505C/en
Priority to EP98919512A priority patent/EP0919241B1/en
Priority to DE1998625395 priority patent/DE69825395T2/de
Publication of WO1998051327A1 publication Critical patent/WO1998051327A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP1998/002031 1997-05-16 1998-05-07 Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats WO1998051327A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU72343/98A AU739107B2 (en) 1997-05-16 1998-05-07 An immune disease remedy, treatment method and preventive agent and method for dogs and cats
CA002265505A CA2265505C (en) 1997-05-16 1998-05-07 An immune disease remedy, treatment method and preventive agent and method for dogs and cats
EP98919512A EP0919241B1 (en) 1997-05-16 1998-05-07 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
DE1998625395 DE69825395T2 (de) 1997-05-16 1998-05-07 Medikament, behandlungsmethode, prophylaktikum und prophylaxe gegen immunologische erkrankungen von hunden und katzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12769097 1997-05-16
JP9/127690 1997-05-16

Publications (1)

Publication Number Publication Date
WO1998051327A1 true WO1998051327A1 (fr) 1998-11-19

Family

ID=14966303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/002031 WO1998051327A1 (fr) 1997-05-16 1998-05-07 Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats

Country Status (6)

Country Link
US (2) US6231850B1 (ja)
EP (1) EP0919241B1 (ja)
AU (1) AU739107B2 (ja)
CA (1) CA2265505C (ja)
DE (1) DE69825395T2 (ja)
WO (1) WO1998051327A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818444B2 (en) 2000-08-04 2004-11-16 Heska Corporation Canine and feline proteins, nucleic acid molecules and uses thereof
CN114807226A (zh) * 2022-05-05 2022-07-29 华南农业大学 一种表达犬il-12的重组质粒及表达犬il-12蛋白的细胞株的制备方法和应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2204186B1 (en) * 1999-02-17 2016-04-06 CSL Limited Immunogenic complexes and methods relating thereto
EP1208115A2 (de) * 1999-07-08 2002-05-29 Mologen Forschungs-, Entwicklungs- und Vertriebs GmbH Interleukin-12 der katze als immunstimulans
US7115712B1 (en) 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
KR100784170B1 (ko) 2006-10-10 2007-12-10 고려대학교 산학협력단 Ｓｕｍｏ 유전자를 이용한 인터루킨-12의 생산 및 분비억제용 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501009A (ja) * 1990-09-18 1994-01-27 ジェネティックス・インスティテュート・インコーポレイテッド ナチュラルキラー刺激因子
JPH0753594A (ja) * 1993-07-02 1995-02-28 F Hoffmann La Roche Ag インターロイキン−１２のｐ４０ホモダイマー
WO1996024676A1 (en) * 1995-02-08 1996-08-15 Whitehead Institute For Biomedical Research Bioactive fusion proteins and pre-existing tumor therapy
JPH1036397A (ja) * 1995-11-08 1998-02-10 Toray Ind Inc イヌインターロイキン１２およびその製造法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2654948B2 (ja) * 1987-07-31 1997-09-17 スズキ株式会社 船外機の音声アラーム出力装置
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
AU702379B2 (en) * 1996-06-04 1999-02-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Novel feline cytokine protein
JP2002241398A (ja) * 1997-06-03 2002-08-28 Chemo Sero Therapeut Res Inst 新規なイヌサイトカインタンパク質

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501009A (ja) * 1990-09-18 1994-01-27 ジェネティックス・インスティテュート・インコーポレイテッド ナチュラルキラー刺激因子
JPH0753594A (ja) * 1993-07-02 1995-02-28 F Hoffmann La Roche Ag インターロイキン−１２のｐ４０ホモダイマー
WO1996024676A1 (en) * 1995-02-08 1996-08-15 Whitehead Institute For Biomedical Research Bioactive fusion proteins and pre-existing tumor therapy
JPH1036397A (ja) * 1995-11-08 1998-02-10 Toray Ind Inc イヌインターロイキン１２およびその製造法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OKANO F., SATOH M., YAMADA K.: "CLONING AND EXPRESSION OF THE CDNA FOR CANINE INTERLEUKIN-12.", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH., MARY ANN LIEBERT, NEW YORK, NY., US, vol. 17., 1 January 1997 (1997-01-01), US, pages 713 - 718., XP002913120, ISSN: 1079-9907 *
SCHIJNS V. E. C. J., ET AL.: "MOLECULAR CLONING OF CAT INTERLEUKIN-12.", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 45., 1 January 1997 (1997-01-01), DE, pages 462/463., XP002913121, ISSN: 0093-7711, DOI: 10.1007/s002510050234 *
See also references of EP0919241A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818444B2 (en) 2000-08-04 2004-11-16 Heska Corporation Canine and feline proteins, nucleic acid molecules and uses thereof
US7205143B2 (en) 2000-08-04 2007-04-17 Heska Corporation Feline IL-12 single chain nucleic acid molecules
US7556963B2 (en) 2000-08-04 2009-07-07 Heska Corporation Feline IL-18 nucleic acid molecules
US7928197B2 (en) 2000-08-04 2011-04-19 Heska Corporation Feline IL-18 proteins
CN114807226A (zh) * 2022-05-05 2022-07-29 华南农业大学 一种表达犬il-12的重组质粒及表达犬il-12蛋白的细胞株的制备方法和应用

Also Published As

Publication number Publication date
AU7234398A (en) 1998-12-08
DE69825395D1 (de) 2004-09-09
DE69825395T2 (de) 2005-01-13
CA2265505A1 (en) 1998-11-19
EP0919241A4 (en) 2002-08-07
EP0919241B1 (en) 2004-08-04
US6231850B1 (en) 2001-05-15
CA2265505C (en) 2009-09-08
US6562334B1 (en) 2003-05-13
EP0919241A1 (en) 1999-06-02
AU739107B2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
ES2170755T3 (es) Conjugados de farmaco antitumoral escindibles por enzimas lisosomales.
AU3434697A (en) Compounds with growth hormone releasing properties
CA2168963A1 (en) Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases
MY104343A (en) Novel pyridizinamine deravatives
CA2211381A1 (en) Compounds with growth hormone releasing properties
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
EP1413303A4 (en) PROMOTERS FOR GROWTH IN PORK AND METHOD FOR PROMOTING GROWTH IN PORK
AU5956398A (en) Remedies for lymphocytic tumors
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
WO1999001467A3 (en) Therapeutically active compounds with low systemic activity due to reduce half life
WO1998051327A1 (fr) Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats
EP0347931A3 (en) Polypeptide comprising repeated cell-adhesive core sequences
AU5913096A (en) An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
EP0188214A3 (en) Novel growth hormone-releasing peptides and method of treating mammals therewith
CA2288341A1 (en) Erythropoietin in the treatment of domestic and livestock animals for anemia
BG104339A (en) Thiadiazole carboxamide derivative, plant disease controlling agent, and methods for using the same
EP1016408A4 (en) C-C CHEMOKINE PRODUCTION INHIBITORS
DE3584250D1 (de) Mittel zum stimulieren des haarwuchses.
HUT47947A (en) Process for producing unsaturated amino acid compounds and pharmaceuticals comprising same as active ingredient
EP1023906A4 (en) AMPLIFIER FOR ANTIBODY AGAINST LYMPHOIDEN TUMOR
WO1988007869A3 (en) ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION
EP1238652A4 (en) COMBINATIONS FOR PEELINGS
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 72343/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998919512

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2265505

Country of ref document: CA

Ref country code: CA

Ref document number: 2265505

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1998919512

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 72343/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998919512

Country of ref document: EP